Guardian Capital Advisors LP Abbott Laboratories Transaction History

Guardian Capital Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $94,438 - $111,159	-975 Reduced 29.55%	2,325 $235,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $14,259 - $16,728	150 Added 4.76%	3,300 $362,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $25,517 - $30,842	-250 Reduced 7.35%	3,150 $333,000
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $142,525 - $173,800	1,250 Added 58.14%	3,400 $403,000
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $27,210 - $32,057	250 Added 13.16%	2,150 $261,000
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $174,116 - $211,451	1,900 New	1,900 $205,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital Advisors LP with notifications on news.